Form 8-K - Current report:
SEC Accession No. 0001104659-25-065979
Filing Date
2025-07-07
Accepted
2025-07-07 08:00:48
Documents
13
Period of Report
2025-07-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2519804d1_8k.htm   iXBRL 8-K 28535
2 EXHIBIT 10.1 tm2519804d1_ex10-1.htm EX-10.1 1075848
  Complete submission text file 0001104659-25-065979.txt   1514993

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pcrx-20250703.xsd EX-101.SCH 3008
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcrx-20250703_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcrx-20250703_pre.xml EX-101.PRE 22354
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2519804d1_8k_htm.xml XML 3691
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 251107009
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)